{Reference Type}: Journal Article
{Title}: Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience.
{Author}: Goyal G;Young JR;Abeykoon JP;Shah MV;Bennani NN;Sartori-Valinotti JC;Vassallo R;Ryu JH;Tobin WO;Koster MJ;Davidge-Pitts CJ;Ravindran A;Rech KL;Go RS;
{Journal}: Oncologist
{Volume}: 27
{Issue}: 2
{Year}: 03 2022 4
{Factor}: 5.837
{DOI}: 10.1093/oncolo/oyab031
{Abstract}: Histiocytic disorders pose significant diagnostic and management challenges for the clinicians due to diverse clinical manifestations and often non-specific histopathologic findings. Herein, we report the tumor board experience from the first-of-its-kind Histiocytosis Working Group (HWG).<BR>The HWG was established in June 2017 and consists of experts from 10 subspecialties that discuss cases in a multidisciplinary format. We present the outcome of tumor board case discussions during the first 2 years since its inception (June 2017-June 2019).<BR>Forty cases with a suspected histiocytic disorder were reviewed at HWG during this time period. Average number of subspecialties involved in HWG case discussion was 5 (range, 2-9). Histiocytosis Working Group tumor board recommendations led to significant changes in the care of 24 (60%) patients. These included change in diagnosis (n = 11, 27%) and change in treatment (n = 13, 33%).<BR>Our report highlights the feasibility of a multidisciplinary tumor board and its impact on outcomes of patients with histiocytic disorders.